Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone versus lactulose in elderly patients with chronic constipation
ChiCTR2400090127Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Sep 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cobiprostone and lactulose in chronic constipation (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: 24-hour spontaneous bowel movement response rate. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
cobiprostonelactulose
03
Conditions
chronic constipation
Beyond the preview
Go deeper on ChiCTR2400090127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090127.